University of Washington

Health Systems and Population Health

SCHOOL OF PUBLIC HEALTH

Estimating Long-Term Survival Outcomes for Tumor-Agnostic Therapies: Larotrectinib Case Study.


  1. Home


  2. Estimating Long-Term Survival Outcomes for Tumor-Agnostic Therapies: Larotrectinib Case Study.


  3. Estimating Long-Term Survival Outcomes for Tumor-Agnostic Therapies: Larotrectinib Case Study.

rakerr2

Briggs A, Paracha N, Rosettie K, Upton A, Bokemeyer C, Lassen U, Sullivan SD. Estimating Long-Term Survival Outcomes for Tumor-Agnostic Therapies: Larotrectinib Case Study. Oncology. 2022;100(2):124-130. doi: 10.1159/000519767. Epub 2021 Nov 29.

Upcoming Events

Full Calendar

News Categories